Publikationen

Dietz A, Wichmann G, Kuhnt T, Pfreundner L, Hagen R, Scheich M, Kolbl O, Hautmann MG, Strutz J, Schreiber F, Bockmuhl U, Schilling V, Feyer P, de Wit M, Maschmeyer G, Jungehulsing M, Schroeder U, Wollenberg B, Sittel C, Munter M, Lenarz T, Klussmann JP, Guntinas-Lichius O, Rudack C, Eich HT, Foerg T, Preyer S, Westhofen M, Welkoborsky HJ, Esser D, Thurnher D, Remmert S, Sudhoff H, Gorner M, Bunzel J, Budach V, Held S, Knodler M, Lordick F, Wiegand S, Vogel K, Boehm A, Flentje M Keilholz U.
Induction chemotherapy (ic) followed by radiotherapy (rt) versus cetuximab plus ic and rt in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial delos-ii.
Annals of oncology : official journal of the European Society for Medical Oncology 2018;29:2105-2114.

Hauswald H, Jensen AD, Krauss J, Haselmann R, Lossner K, Hartmann S, Windemuth-Kieselbach C, Munter M, W Debus J.
Phase ii study of induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil followed by radioimmunotherapy with cetuximab and intensity-modulated radiotherapy in combination with a carbon ion boost for locally advanced tumors of the oro-, hypopharynx and larynx.
Clinical and translational radiation oncology 2018;13:64-73.

Sparber-Sauer M, Seitz G, von Kalle T, Vokuhl C, Leuschner I, Scheer M, Munter M, Ljungman G, Bielack SS, Niggli F, Ladenstein R, Klingebiel T, Fuchs J, Koscielniak E Group CWSS.
Systemic therapy of aggressive fibromatosis in children and adolescents: Report of the cooperative weichteilsarkom studiengruppe (cws).
Pediatric blood & cancer 2018;65:e26943.

Sparber-Sauer M, Seitz G, von Kalle T, Vokuhl C, Scheer M, Munter M, Bielack SS, Kazanowska B, Ladenstein R, Niggli F, Klingebiel T, Fuchs J, Koscielniak E Group CWSS.
Alveolar soft-part sarcoma: Primary metastatic disease and metastatic relapse occurring during long-term follow-up: Treatment results of four cooperative weichteilsarkom studiengruppe (cws) trials and one registry.
Pediatric blood & cancer 2018;65:e27405.

Sterzing F, Hoehle F, Ulrich A, Jensen A, Debus J, Muenter M.
Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients.
J Radiat Res. 2015

Jensen AD, Nikoghosyan AV, Lossner K, Haberer T, Jäkel O, Münter MW, Debus J.
COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results of the Prospective Phase 2 Trial.
Int J Radiat Oncol Biol Phys. 2015
   
Jensen AD, Poulakis M, Nikoghosyan AV, Welzel T, Uhl M, Federspil PA, Freier K, Krauss J, Höss A, Haberer T, Jäkel O, Münter MW, Schulz-Ertner D, Huber PE, Debus J.
High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years' experience with raster-scanned carbon ion therapy.
Radiother Oncol. 2015
   
Jensen AD, Nikoghosyan AV, Poulakis M, Höss A, Haberer T, Jäkel O, Münter MW, Schulz-Ertner D, Huber PE, Debus J.
Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.
Cancer. 2015 Sep
  
Jensen AD, Poulakis M, Nikoghosyan AV, Chaudhri N, Uhl M, Münter MW, Herfarth KK, Debus J.
Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy.
Radiother Oncol. 2015

Münter M, Welker H, Jensen A, Wegner N:
Stereotactic radiosurgery (SRS) and stereotactic radiation therapy (SRT) for neurooncological and neurological diseases: state of the art and future perspectives.
Innovative Neurosurgery 2014; Epub ahead of print

Hauser T, Essig M, Jensen A, Laun FB, Münter M, Maier-Hein KH, Stieltjes B.
Prediction of treatment response in head and neck carcinomas using IVIM-DWI: Evaluation of lymph node metastasis. Eur J Radiol. 2014 May;83(5):783-7

Seufferlein T, Porzner M, Becker T, Budach V, Ceyhan G, Esposito I, Fietkau R, Follmann M, Friess H, Galle P, Geißler M, Glanemann M, Gress T, Heinemann V, Hohenberger W, Hopt U, Izbicki J, Klar E, Kleeff J, Kopp I, Kullmann F, Langer T, Langrehr J, Lerch M, Löhr M, Lüttges J, Lutz M, Mayerle J, Michl P, Möller P, Molls M, Münter M, Nothacker M, Oettle H, Post S, Reinacher-Schick A, Röcken C, Roeb E, Saeger H, Schmid R, Schmiegel W, Schoenberg M, Siveke J, Stuschke M, Tannapfel A, Uhl W, Unverzagt S, van Oorschot B, Vashist Y, Werner J, Yekebas E;
S3 -guideline exocrine pancreatic cancer. Guidelines Programme Oncology AWMF; German Cancer Society eV; German Cancer Aid. Z Gastroenterol. 2013 Dec;51(12):1395-440.

Ganten MK, Schuessler M, Bäuerle T, Münter M et al:
The role of perfusion effects in monitoring of chemoradiotherapy of rectal-carcinoma using diffusion-weighted imaging.
Cancer Imaging 2013; 13(4):548-56

Saleh-Ebrahimi L, Zwicker F, Münter M et al:
Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer – a retrospective single center analysis.
Radiation Oncology 2013; 8:20

Köppen U:
Prostatakarzinom. Alternativen zur radikalen Operation.
Schattauer: Stuttgart/New York, 4. Aufl. 2012

Jensen AD, Krauss J, Potthoff K, Simon C, Nikoghosyan AV, Lossner K, Debus J, Münter M:
Radiochemoimmunotherapy with intensity-modulated concomitant boost: Interim analysis of the REACH trial.
Radiation Oncology 7 (2012); 57

Münter M, Welker H, Keller K:
Radioonkologische Entwicklungen und Behandlungskonzepte neuroonkologischer Tumorerkrankungen.
Nervenheilkunde 31, 9 (2012); 615-620

Köppen U:
Partialbrustbestrahlung nach Mammakarzinom.
Onkologische Welt 3, 5 (2012); 219-225

Jensen AD, Nill S, Huber PE, Bendl R, Debus J, Münter M:
A clinical concept for interfractional adaptive radiation therapy in the treatment of head and neck cancer.
International Journal of Radiation Oncology, Biology, Physics 82 (2012); 590-596

Jensen AD, Winter M, Kuhn SP, Debus J, Nairz O, Münter MW:
Robotic-based carbon ion therapy and patient positioning in 6 degrees of freedom: Setup accuracy of two standard immobilization devices used in carbon ion therapy and IMRT.
Radiation Oncology 7 (2012); 51

Jensen AD, Nikoghosyan AV, Lossner K, Herfarth KK, Debus J, Münter M:
Imrt and carbon ion boost for malignant salivary gland tumors: Interim analysis of the cosmic trial.
BMC Cancer 12 (2012); 163

Münter M: Koautor bei 13 internationalen Publikationen, u.a.:
Rieken, S et al: Assessment of early toxicity and response in patients treated with proton and carbon ion therapy at the Heidelberg Ion Therapy Center using the raster scanning technique.
Int J Radiat Oncol Biol Phys 81,5 (2011), e793-801; Zwicker et al: IMRT reirradiation with concurrent cetuximab immunotherapy in recurrent head and neck cancer. Strahlenther Onkol 187, 1 (2011), 582-589; Jensen, A et al: Combined treatment of nonsmall lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: the NEAR triel. Cancer 117, 13 (2011), 2986-2994

Welker H: Koautor bei Müller, K et al:
Curative treatment for central nervous system medulloepithelioma despite residual disease after resection.
Strahlenther Onkol 187, 11 (2011), 757-762